Oxford Instruments PLC Interim Management Statement (7429X)
13 2월 2013 - 4:00PM
UK Regulatory
TIDMOXIG
RNS Number : 7429X
Oxford Instruments PLC
13 February 2013
Release date: 13 February 2013
Oxford Instruments plc
Interim Management Statement
Oxford Instruments plc, a leading provider of high technology
tools and systems for industry and research, today issues an
Interim Management Statement which covers the period from 1 October
2012 to date.
The trend seen in the first half of the year has continued with
growth in the Nanotechnology Tools sector and continued softness in
the Industrial Products sector as reported in our half year
statement. The Service sector continues to grow as we integrate our
existing business with the Platinum Medical Imaging business that
we acquired last year.
Our broad spread of geographies and technologies, and our strong
pipeline of new products help us to remain resilient in the current
uncertain economic environment. The Board anticipates that Oxford
Instruments will continue to make good progress, in line with its
expectations for the remainder of the financial year and consistent
with its 14 cubed objectives.
On 17 December 2012 the Group announced the acquisition of
Asylum Research Corporation ("Asylum Research"), a leading provider
of Scanning Probe Microscopes (SPM) for an initial debt free, cash
free consideration of US$32.0 million with a deferred element of up
to US$48.0 million payable over three years dependent on its
performance over that period.
Save as described in this statement, there has been no
significant change in the financial position of the Group in the
period.
- Ends -
Enquiries:
Oxford Instruments plc Tel: 01865 393200
Jonathan Flint, Chief Executive
Kevin Boyd, Group Finance Director
MHP Communications Tel: 020 3128 8100
Rachel Hirst / Ian Payne
Issued for and on behalf of Oxford Instruments plc
Notes to Editors
About Oxford Instruments plc
Oxford Instruments designs, supplies and supports
high-technology tools and systems with a focus on research and
industrial applications. It provides solutions needed to advance
fundamental physics research and its transfer into commercial
nanotechnology applications. Innovation has been the driving force
behind Oxford Instruments' growth and success for over 50 years,
and its strategy is to effect the successful commercialisation of
these ideas by bringing them to market in a timely and
customer-focused fashion.
The first technology business to be spun out from Oxford
University over fifty years ago, Oxford Instruments is now a global
company with over 1900 staff worldwide and is listed on the FTSE250
index of the London Stock Exchange (OXIG). Its objective is to be
the leading provider of new generation tools and systems for the
research and industrial sectors.
This involves the combination of core technologies in areas such
as low temperature, high magnetic field and ultra high vacuum
environments, Nuclear Magnetic Resonance, X-ray, electron and
optical based metrology, and advanced growth, deposition and
etching.
Oxford Instruments aims to pursue responsible development and
deeper understanding of our world through science and technology.
Its products, expertise, and ideas address global issues such as
energy, environment, security and health.
This information is provided by RNS
The company news service from the London Stock Exchange
END
IMSBRGDDIBBBGXD
Oxford Instruments (LSE:OXIG)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Oxford Instruments (LSE:OXIG)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024